share_log

Raymond James Initiates Coverage On Pacira BioSciences With Outperform Rating, Announces Price Target of $42

Raymond James Initiates Coverage On Pacira BioSciences With Outperform Rating, Announces Price Target of $42

雷蒙德·詹姆斯以跑赢大盘的评级发起对Pacira BioSciences的报道,宣布目标股价为42美元
Benzinga ·  2023/12/20 06:31

Raymond James analyst Gary Nachman initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Outperform rating and announces Price Target of $42.

雷蒙德·詹姆斯分析师加里·纳赫曼以跑赢大盘的评级开始对Pacira BioSciences(纳斯达克股票代码:PCRX)进行报道,并宣布目标股价为42美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发